116 related articles for article (PubMed ID: 25422586)
1. Inhibition of cardiac Kv1.5 potassium current by the anesthetic midazolam: mode of action.
Vonderlin N; Fischer F; Zitron E; Seyler C; Scherer D; Thomas D; Katus HA; Scholz EP
Drug Des Devel Ther; 2014; 8():2263-71. PubMed ID: 25422586
[TBL] [Abstract][Full Text] [Related]
2. Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.
Vonderlin N; Fischer F; Zitron E; Seyler C; Scherer D; Thomas D; Katus HA; Scholz EP
Drug Des Devel Ther; 2015; 9():867-77. PubMed ID: 25733807
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of hesperetin on Kv1.5 potassium channels stably expressed in HEK 293 cells and ultra-rapid delayed rectifier K(+) current in human atrial myocytes.
Wang H; Wang HF; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
Eur J Pharmacol; 2016 Oct; 789():98-108. PubMed ID: 27397430
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action.
Fischer F; Vonderlin N; Zitron E; Seyler C; Scherer D; Becker R; Katus HA; Scholz EP
Naunyn Schmiedebergs Arch Pharmacol; 2013 Nov; 386(11):991-9. PubMed ID: 23832378
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.
Jeong I; Choi BH; Yoon SH; Hahn SJ
Biochem Pharmacol; 2012 Feb; 83(4):497-505. PubMed ID: 22146582
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants of Kv1.5 channel block by diphenyl phosphine oxide-1.
Du YM; Zhang XX; Tu DN; Zhao N; Liu YJ; Xiao H; Sanguinetti MC; Zou A; Liao YH
J Mol Cell Cardiol; 2010 Jun; 48(6):1111-20. PubMed ID: 20184887
[TBL] [Abstract][Full Text] [Related]
7. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
Lagrutta A; Wang J; Fermini B; Salata JJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
[TBL] [Abstract][Full Text] [Related]
8. SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5.
Benson MD; Li QJ; Kieckhafer K; Dudek D; Whorton MR; Sunahara RK; Iñiguez-Lluhí JA; Martens JR
Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1805-10. PubMed ID: 17261810
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of cortisone and hydrocortisone on human Kv1.5 channel currents.
Yu J; Park MH; Jo SH
Eur J Pharmacol; 2015 Jan; 746():158-66. PubMed ID: 25449034
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
[TBL] [Abstract][Full Text] [Related]
11. Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation.
Decher N; Kumar P; Gonzalez T; Pirard B; Sanguinetti MC
Mol Pharmacol; 2006 Oct; 70(4):1204-11. PubMed ID: 16835355
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of voltage-gated potassium channel Kv1.5--impact on cardiac excitability.
Wettwer E; Terlau H
Curr Opin Pharmacol; 2014 Apr; 15():115-21. PubMed ID: 24632326
[TBL] [Abstract][Full Text] [Related]
13. Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels.
Zhang HX; Zhang W; Jin HW; Wang XL
Brain Res Mol Brain Res; 2004 Nov; 131(1-2):136-40. PubMed ID: 15530663
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of cholinesterase inhibitor donepezil on the Kv1.5 potassium channel.
Li K; Cheng N; Li XT
Sci Rep; 2017 Feb; 7():41509. PubMed ID: 28198801
[TBL] [Abstract][Full Text] [Related]
15. Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea?
Kiper AK; Rinné S; Rolfes C; Ramírez D; Seebohm G; Netter MF; González W; Decher N
Pflugers Arch; 2015 May; 467(5):1081-90. PubMed ID: 25511502
[TBL] [Abstract][Full Text] [Related]
16. Intravenous anesthetic propofol inhibits multiple human cardiac potassium channels.
Yang L; Liu H; Sun HY; Li GR
Anesthesiology; 2015 Mar; 122(3):571-84. PubMed ID: 25321870
[TBL] [Abstract][Full Text] [Related]
17. Separation of P/C- and U-type inactivation pathways in Kv1.5 potassium channels.
Kurata HT; Doerksen KW; Eldstrom JR; Rezazadeh S; Fedida D
J Physiol; 2005 Oct; 568(Pt 1):31-46. PubMed ID: 16020465
[TBL] [Abstract][Full Text] [Related]
18. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
Arias C; Guizy M; David M; Marzian S; González T; Decher N; Valenzuela C
Anesthesiology; 2007 Oct; 107(4):641-51. PubMed ID: 17893461
[TBL] [Abstract][Full Text] [Related]
19. Kv1.1 channels of dorsal root ganglion neurons are inhibited by n-butyl-p-aminobenzoate, a promising anesthetic for the treatment of chronic pain.
Beekwilder JP; O'Leary ME; van den Broek LP; van Kempen GT; Ypey DL; van den Berg RJ
J Pharmacol Exp Ther; 2003 Feb; 304(2):531-8. PubMed ID: 12538804
[TBL] [Abstract][Full Text] [Related]
20. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.
Fedida D; Eldstrom J; Hesketh JC; Lamorgese M; Castel L; Steele DF; Van Wagoner DR
Circ Res; 2003 Oct; 93(8):744-51. PubMed ID: 14500335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
